Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 11, Number 9—September 2005
Historical Review

Malaria in Kenya's Western Highlands

G. Dennis Shanks*Comments to Author , Simon I. Hay†‡, Judy A. Omumbo‡, and Robert W. Snow‡§
Author affiliations: *US Army Medical Research Unit–Kenya, Nairobi, Kenya; †University of Oxford, Oxford, United Kingdom; ‡Kenya Medical Research Institute, Nairobi, Kenya; §John Radcliffe Hospital, Oxford, United Kingdom

Main Article

Figure 3

Monthly malaria cases on the Kericho tea estates, Kenya, 1942–1952, showing mass administration of proguanil. Data were obtained from Strangeways-Dixon (17) and hospital records.

Figure 3. . Monthly malaria cases on the Kericho tea estates, Kenya, 1942–1952, showing mass administration of proguanil. Data were obtained from Strangeways-Dixon (17) and hospital records.

Main Article

References
  1. Abeku  TA, van Oortmarssen  GJ, Borsboom  G, de Vlas  SJ, Habbema  JD. Spatial and temporal variations of malaria epidemic risk in Ethiopia: factors involved and implications. Acta Trop. 2003;87:331–40. DOIPubMedGoogle Scholar
  2. Lindblade  KA, O'Neill  DB, Mathanga  DP, Katungu  J, Wilson  ML. Treatment for clinical malaria is sought promptly during an epidemic in a highland region of Uganda. Trop Med Int Health. 2000;5:865–75. DOIPubMedGoogle Scholar
  3. Malakooti  MA, Biomndo  K, Shanks  GD. Re-emergence of epidemic malaria in the highlands of western Kenya. Emerg Infect Dis. 1998;4:671–6. DOIPubMedGoogle Scholar
  4. Shanks  GD, Biomndo  K, Guyatt  HL, Snow  RW. Travel as a risk factor for uncomplicated Plasmodium falciparum malaria in the highlands of western Kenya. Trans R Soc Trop Med Hyg. 2005;99:71–4. DOIPubMedGoogle Scholar
  5. Roberts  JM. The control of epidemic malaria in the highlands of western Kenya. 3. After the campaign. J Trop Med Hyg. 1964;67:230–7.PubMedGoogle Scholar
  6. Rogers  DJ, Randolph  SE, Snow  RW, Hay  SI. Satellite imagery in the study and forecast of malaria. Nature. 2002;415:710–5. DOIPubMedGoogle Scholar
  7. Shanks  GD, Hay  SI, Stern  DI, Biomndo  K, Snow  RW. Meteorologic influences on Plasmodium falciparum malaria in the highland tea estates of Kericho, western Kenya. Emerg Infect Dis. 2002;8:1404–8.PubMedGoogle Scholar
  8. Hay  SI, Cox  J, Rogers  DJ, Randolph  SE, Stern  DI, Shanks  GD, Climate change and the resurgence of malaria in the east African highlands. Nature. 2002;415:905–9. DOIPubMedGoogle Scholar
  9. Hay  SI, Simba  M, Busolo  M, Noor  AM, Guyatt  HL, Ochola  SA, Defining and detecting malaria epidemics in the highlands of western Kenya. Emerg Infect Dis. 2002;8:555–62.PubMedGoogle Scholar
  10. Shretta  R, Omumbo  J, Rapuoda  B, Snow  RW. Using evidence to change antimalarial drug policy in Kenya. Trop Med Int Health. 2000;5:755–64. DOIPubMedGoogle Scholar
  11. Spencer  HC, Kaseje  DC, Brandling-Bennett  AD, Oloo  AJ, Churchill  FC, Koech  DK. Changing response to chloroquine of Plasmodium falciparum in Saradidi, Kenya, from 1981 to 1984. Ann Trop Med Parasitol. 1987;81(Suppl 1):98–104.PubMedGoogle Scholar
  12. Masaba  SC, Anyona  DB, Chepkwoni  DK. In vitro response of Plasmodium falciparum to chloroquine in the Nandi district, Kenya. Bull World Health Organ. 1985;63:593–5.PubMedGoogle Scholar
  13. Rapuoda  BA, Ouma  JH, Njagi  K, Khan  B, Omar  S. Status of antimalarial drugs sensitivity in Kenya. Malaria and Infectious Diseases in Africa. 1996;8:25–43.
  14. Shanks  GD, Biomndo  K, Hay  SI, Snow  RW. Changing patterns of clinical malaria since 1965 in a highland area of Kenya: possible role of drug resistance. Trans R Soc Trop Med Hyg. 2000;94:253–5. DOIPubMedGoogle Scholar
  15. Matson  AT. The history of malaria in Nandi. East Afr Med J. 1957;34:431–41.PubMedGoogle Scholar
  16. Chataway  JHH. Report on the malaria epidemic in the Lumbwa Reserve (August, 1928). Kenya and East African Medical Journal. 1929;5:303–9.
  17. Strangeways-Dixon  D. Paludrine (proguanil) as a malarial prophylactic amongst African labour in Kenya. East Afr Med J. 1950;27:127–30.PubMedGoogle Scholar
  18. Garnham  PCC. Malaria epidemics at exceptionally high altitudes in Kenya. BMJ. 1945;2:45–7. DOIPubMedGoogle Scholar
  19. Marsh  K, Forster  D, Waruiru  C, Mwangi  I, Winstanley  M, Marsh  V, Indicators of life-threatening malaria in African children. N Engl J Med. 1995;332:1399–404. DOIPubMedGoogle Scholar
  20. Hay  SI, Noor  AM, Simba  M, Busolo  M, Guyatt  HL, Ochola  SA, Clinical epidemiology of malaria in the highlands of western Kenya. Emerg Infect Dis. 2002;8:543–8.PubMedGoogle Scholar
  21. Shanks  GD, Biomndo  K, Maguire  J. Travel as a risk factor for malaria requiring hospitalization on a highland tea plantation in western Kenya. J Travel Med. 2004;11:354–7.PubMedGoogle Scholar
  22. Zucker  JR, Ruebush  TK II, Obonyo  C, Otieno  J, Campbell  CC. The mortality consequences of the continued use of chloroquine in Africa: experience in Siaya, western Kenya. Am J Trop Med Hyg. 2003;68:386–90.PubMedGoogle Scholar
  23. Abeku  TA, Hay  SI, Ochola  S, Langi  P, Beard  B, de Vlas  SJ, Malaria epidemic early warning and detection in African highlands. Trends Parasitol. 2004;20:400–5. DOIPubMedGoogle Scholar
  24. Hay  SI, Were  EC, Renshaw  M, Noor  AM, Ochola  SA, Olusanmi  I, Forecasting, warning, and detection of malaria epidemics: a case study. Lancet. 2003;361:1705–6. DOIPubMedGoogle Scholar
  25. Sutherland  CJ, Alloueche  A, Curtis  J, Drakeley  CJ, Ord  R, Duraisingh  M, Gambian children successfully treated with chloroquine can harbor and transmit Plasmodium falciparum gametocytes carrying resistance genes. Am J Trop Med Hyg. 2002;67:578–85.PubMedGoogle Scholar
  26. Shute  PG, Maryon  M. The effect of pyrimethamine (daraprim) on the gametocytes and oocytsts of Plasmodium falciparum and Plasmodium vivax. Trans R Soc Trop Med Hyg. 1954;48:50–63. DOIPubMedGoogle Scholar
  27. Robert  V, Awono-Ambene  HP, Le Hesran  JY, Trape  JF. Gametocytemia and infectivity to mosquitoes of patients with uncomplicated Plasmodium falciparum malaria attacks treated with chloroquine or sulfadoxine plus pyrimethamine. Am J Trop Med Hyg. 2000;62:210–6.PubMedGoogle Scholar
  28. Hogh  B, Gamage-Mendis  A, Butcher  GA, Thompson  R, Begtrup  K, Mendis  C, The differing impact of chloroquine and pyrimethamine/sulfadoxine upon the infectivity of malaria species to the mosquito vector. Am J Trop Med Hyg. 1998;58:176–82.PubMedGoogle Scholar
  29. Roberts  JM. Pyrimethamine (Daraprim) in the control of epidemic malaria. J Trop Med Hyg. 1956;59:201–8.PubMedGoogle Scholar
  30. Nosten  F, van Vugt  M, Price  R, Luxemburger  C, Thway  KL, Brockman  A, Effects of artesunate-mefloquine combination on incidence of Plasmodium falciparum malaria and mefloquine resistance in western Thailand: a prospective study. Lancet. 2000;356:297–302. DOIPubMedGoogle Scholar
  31. von Seidlein  L, Milligan  P, Pinder  M, Bojang  K, Anyalebechi  C, Gosling  R, Efficacy of artesunate plus pyrimethamine-sulphadoxine for uncomplicated malaria in Gambian children: a double-blind, randomised, controlled trial. Lancet. 2000;355:352–7. DOIPubMedGoogle Scholar
  32. Hay  SI, Myers  MF, Burke  DS, Vaughn  D, Endy  T, Ananda  N, Etiology of mosquito-borne disease epidemics. Proc Natl Acad Sci U S A. 2000;97:9335–9. DOIPubMedGoogle Scholar
  33. Thomas  C. Malaria: a changed climate in Africa? Nature. 2004;427:690–1. DOIPubMedGoogle Scholar
  34. Small  J, Goetz  SJ, Hay  SI. Climatic suitability for malaria transmission in Africa, 1911–1995. Proc Natl Acad Sci U S A. 2003;100:15341–5. DOIPubMedGoogle Scholar
  35. Snow  RW, Ikoku  A, Omumbo  J, Ouma  J. The epidemiology, politics and control of malaria epidemics in Kenya: 1900–1998. Nairobi, Kenya: World Health Organization. Report prepared for Roll Back Malaria, Resource Network on Epidemics; July 1999.
  36. Greenberg  AE. Hospital-based surveillance of malaria-related paediatric morbidity and mortality in Kinshasa, Zaire. Bull World Health Organ. 1989;67:189–96.PubMedGoogle Scholar
  37. Bodker  R, Kisinza  W, Malima  R, Hsangeni  H, Lindsay  SW. Resurgence of malaria in the Usambara mountains, Tanzania, an epidemic of drug-resistant parasites. Glob Change Hum Health. 2000;1:134–53. DOIGoogle Scholar
  38. Ndyomugyenyi  R, Magnussen  P. Malaria morbidity, mortality and pregnancy outcome in areas with different levels of malaria transmission in Uganda: a hospital record-based study. Trans R Soc Trop Med Hyg. 2001;95:463–8. DOIPubMedGoogle Scholar
  39. Brooker  S, Clarke  S, Njagi  JK, Polack  S, Mugo  B, Estambale  B, Spatial clustering of malaria and associated risk factors during an epidemic in a highland area of western Kenya. Trop Med Int Health. 2004;9:757–66. DOIPubMedGoogle Scholar
  40. East African Network for Monitoring Antimalarial Treatment (EANMAT). The efficacy of antimalarial monotherapies, sulphadoxine-pyrimethamine and amodiaquine in east Africa: implications for sub-regional policy. Trop Med Int Health. 2003;8:860–7. DOIPubMedGoogle Scholar
  41. Muheki  C, McIntyre  D, Barnes  KI. Artemisinin-based combination therapy reduces expenditure on malaria treatment in KwaZulu Natal, South Africa. Trop Med Int Health. 2004;9:959–66. DOIPubMedGoogle Scholar

Main Article

Page created: April 23, 2012
Page updated: April 23, 2012
Page reviewed: April 23, 2012
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external